Meta-analysis of cranial CT scans in children: A mathematical model to predict radiation-induced tumors

Pediatric Neurosurgery

Volumn 44, Issue 6, 2009, Pages 448-457

  Stein, Sherman C ^a,b   Hurst, Robert W ^a   Sonnad, Seema S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Astrocytoma; Cranial CT scan; Glioblastoma multiforme; Meningioma; Radiation induced tumor; Thyroid carcinoma

Indexed keywords

ARTICLE; CANCER RISK; COMPUTER ASSISTED TOMOGRAPHY; GLIOMA; HUMAN; MENINGIOMA; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RADIATION EXPOSURE; THYROID CARCINOMA;

BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; MODELS, NEUROLOGICAL; NEOPLASMS, RADIATION-INDUCED; PREDICTIVE VALUE OF TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 56149127127     PISSN: 10162291     EISSN: None     Source Type: Journal    
DOI: 10.1159/000172967     Document Type: Article

References (123)

1. Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation NRC: Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. Washington, National Academies Press, 2005.
2. Khursheed A, Hillier MC, Shrimpton PC, Wall BF: Influence of patient age on normalized effective doses calculated for CT examinations. Br J Radiol 2002;75:819-830.
3. Theocharopoulos N, Damilakis J, Perisinakis K, Tzedakis A, Karantanas A, Gourtsoyiannis N: Estimation of effective doses to adult and pediatric patients from multislice computed tomography: a method based on energy imparted. Med Phys 2006;33:3846-3856.
4. Vock P: CT dose reduction in children. Eur Radiol 2005;15:2330-2340.
5. Huda W, Vance A: Patient radiation doses from adult and pediatric CT. AJR Am J Roentgenol 2007;188:540-546.
6. McCollough CH, Schueler BA: Calculation of effective dose. Med Phys 2000;27:828-837.
7. Anonymous: 1990 Recommendations of the International Commission on Radiological Protection. New York, International Commission on Radiological Protection, 1990, No 1-3.
8. American Academy of Pediatrics, Committee on Environmental Health: Risk of ionizing radiation exposure to children: a subject review. Pediatrics 1998;101:717-719.
9. Frush DP, Donnelly LF, Rosen NS: Computed tomography and radiation risks: what pediatric health care providers should know. Pediatrics 2003;112:951-957.
10. National Research Council Committee on the Biological Effects of Ionizing Radiation: Health Effects of Exposure to Low Levels of Ionizing Radiation. Washington, National Academy Press, 1990.
11. Wilson-Costello D, Rao PS, Morrison S, Hack M: Radiation exposure from diagnostic radiographs in extremely low birth weight infants. Pediatrics 1996;97:369-374.
12. Brenner D, Elliston C, Hall E, Berdon W: Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol 2001;176:289-296.
13. Durham SR, Liu KC, Selden NR: Utility of serial computed tomography imaging in pediatric patients with head trauma. J Neurosurg 2006;105(suppl 5):365-369.
14. Herbert M: Issues in minor head injury: to CT or not to CT, that is the question. Emerg Radiol 2000;7:7-13.
15. Huda W, Chamberlain CC, Rosenbaum AE, Garrisi W: Radiation doses to infants and adults undergoing head CT examinations. Med Phys 2001;28:393-399.
16. Macgregor DM, McKie L: CT or not CT - that is the question: Whether 'tis better to evaluate clinically and x ray than to undertake a CT head scan! Emerg Med J 2005;22:541-543.
17. Thierry-Chef I, Simon SL, Miller DL: Radiation dose and cancer risk among pediatric patients undergoing interventional neuroradiology procedures. Pediatr Radiol 2006;36(suppl 14):159-162.
18. Brenner DJ, Hall EJ: Computed tomography - an increasing source of radiation exposure. N Engl J Med 2007;357:2277-2284.
19. Pages J, Buls N, Osteaux M: CT doses in children: a multicentre study. Br J Radiol 2003;76:803-811.
20. National Institute for Clinical Excellence: Head injury triage, assessment, investigation and early management of head injury in infants, children and adults. London, National Institute for Clinical Excellence, 2003. http://www.nice.org.uk/page.aspx?o=56817 (accessed June 6, 2007).
21. Mettler FA Jr, Wiest PW, Locken JA, Kelsey CA: CT scanning: patterns of use and dose. J Radiol Prot 2000;20:353-359.
22. Paterson A, Frush DP: Dose reduction in paediatric MDCT: general principles. Clin Radiol 2007;62:507-517.
23. Lee CI, Haims AH, Monico EP, Brink JA, Forman HP: Diagnostic CT scans: assessment of patient, physician, and radiologist awareness of radiation dose and possible risks. Radiology 2004;231:393-398.
24. Rogers LF: Taking care of children: check out the parameters used for helical CT. AJR Am J Roentgenol 2001;176:287.
25. Donnelly LF, Frush DP: Fallout from recent articles on radiation dose and pediatric CT. Pediatr Radiol 2001;31:388; discussion 389-391.
26. Huda W, Lieberman KA, Chang J, Roskopf ML: Patient size and x-ray technique factors in head computed tomography examinations. I. Radiation doses. Med Phys 2004;31:588-594.
27. Brenner DJ: Estimating cancer risks from pediatric CT: going from the qualitative to the quantitative. Pediatr Radiol 2002;32:228-233; discussion 242-244.
28. Ron E, Modan B, Boice JD Jr, et al: Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 1988;319:1033-1039.
29. Sadetzki S, Chetrit A, Freedman L, Stovall M, Modan B, Novikov I: Long-term follow-up for brain tumor development after childhood exposure to ionizing radiation for tinea capitis. Radiat Res 2005;163:424-432.
30. Sadetzki S, Chetrit A, Lubina A, Stovall M, Novikov I: Risk of thyroid cancer after childhood exposure to ionizing radiation for tinea capitis. J Clin Endocrinol Metab 2006;91:4798-4804.
31. Sadetzki S, Flint-Richter P, Ben-Tal T, Nass D: Radiation-induced meningioma: a descriptive study of 253 cases. J Neurosurg 2002;97:1078-1082.
32. Preston DL, Ron E, Yonehara S, et al: Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst 2002;94:1555-1563.
33. Yonehara S, Brenner AV, Kishikawa M, et al: Clinical and epidemiologic characteristics of first primary tumors of the central nervous system and related organs among atomic bomb survivors in Hiroshima and Nagasaki, 1958-1995. Cancer 2004;101:1644-1654.
34. Steliarova-Foucher E, Stiller CA, Pukkala E, Lacour B, Plesko I, Parkin DM: Thyroid cancer incidence and survival among European children and adolescents (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006;42:2150-2169.
35. De Vathaire F, Hardiman C, Shamsaldin A, et al: Thyroid carcinomas after irradiation for a first cancer during childhood. Arch Intern Med 1999;159:2713-2719.
36. Ron E, Lubin JH, Shore RE, et al: Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995;141:259-277.
37. Musa BS, Pople IK, Cummins BH: Intracranial meningiomas following irradiation - a growing problem? Br J Neurosurg 1995;9:629-637.
38. Pollak L, Walach N, Gur R, Schiffer J: Meningiomas after radiotherapy for tinea capitis - still no history. Tumori 1998;84:65-68.
39. Liwnicz BH, Berger TS, Liwnicz RG, Aron BS: Radiation-associated gliomas: a report of four cases and analysis of postradiation tumors of the central nervous system. Neurosurgery 1985;17:436-445.
40. McIver JI, Pollock BE: Radiation-induced tumor after stereotactic radiosurgery and whole brain radiotherapy: case report and literature review. J Neurooncol 2004;66:301-305.
41. Minniti G, Traish D, Ashley S, Gonsalves A, Brada M: Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. J Clin Endocrinol Metab 2005;90:800-804.
42. Neglia JP, Robison LL, Stovall M, et al: New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2006;98:1528-1537.
43. Salvati M, Frati A, Russo N, et al: Radiation-induced gliomas: report of 10 cases and review of the literature. Surg Neurol 2003;60:60-67; discussion 67.
44. Simmons NE, Laws ER Jr: Glioma occurrence after sellar irradiation: case report and review. Neurosurgery 1998;42:172-178.
45. Arias E: United States Life Tables, 2001. Natl Vital Stat Rep 2004;52:1-38.
46. King JT Jr, Berlin JA, Flamm ES: Morbidity and mortality from elective surgery for asymptomatic, unruptured, intracranial aneurysms: a meta-analysis. J Neurosurg 1994;81:837-842.
47. Einarson TR: Pharmacoeconomic applications of meta-analysis for single groups using antifungal onychomycosis lacquers as an example. Clin Ther 1997;19:559-569; discussion 538-539.
48. Gold M, Siegel J, Russell L, Weinstein M: Cost-Effectiveness in Health and Medicine. New York, Oxford University Press, 1996.
49. Sonnenberg FA, Beck JR: Markov models in medical decision making: a practical guide. Med Decis Making 1993;13:322-338.
50. Salvati M, Artico M, Caruso R, Rocchi G, Orlando ER, Nucci F: A report on radiation-induced gliomas. Cancer 1991;67:392-397.
51. Colonna M, Grande E, Jonasson JG, Eurocare Working G: Variation in relative survival of thyroid cancers in Europe: results from the analysis on 21 countries over the period 1983-1994 (EUROCARE-3 study). Eur J Cancer 2006;42:2598-2608.
52. Roman S, Lin R, Sosa JA: Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. Cancer 2006;107:2134-2142.
53. Curry WT, McDermott MW, Carter BS, Barker FG 2nd: Craniotomy for meningioma in the United States between 1988 and 2000: decreasing rate of mortality and the effect of provider caseload. J Neurosurg 2005;102:977-986.
54. Condra KS, Buatti JM, Mendenhall WM, Friedman WA, Marcus RB Jr, Rhoton AL: Benign meningiomas: primary treatment selection affects survival. Int J Radiat Oncol Biol Phys 1997;39:427-436.
55. Helseth A: Incidence and survival of intracranial meningioma patients in Norway 1963-1992. Neuroepidemiology 1997;16:53-59.
56. McCarthy BJ, Davis FG, Freels S, et al: Factors associated with survival in patients with meningioma. J Neurosurg 1998;88:831-839.
57. Mihaila D, Jankowski M, Gutierrez JA, et al: Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival. Clin Cancer Res 2003;9:4443-4451.
58. Sankila R, Kallio M, Jaaskelainen J, Hakulinen T. Long-term survival of 1986 patients with intracranial meningioma diagnosed from 1953 to 1984 in Finland: comparison of the observed and expected survival rates in a population-based series. Cancer 1992;70:1568-1576.
59. Bohinski RJ, Kokkino AK, Warnick RE, et al: Glioma resection in a shared-resource magnetic resonance operating room after optimal image-guided frameless stereotactic resection. Neurosurgery 2001;48:731-742; discussion 742-744.
60. Brell M, Ibanez J, Caral L, Ferrer E: Factors influencing surgical complications of intraaxial brain tumours. Acta Neurochir (Wien) 2000;142:739-750.
61. Chang SM, Parney IF, McDermott M, et al: Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg 2003;98:1175-1181.
62. Devaux BC, O'Fallon JR, Kelly PJ: Resection, biopsy, and survival in malignant glial neoplasms: a retrospective study of clinical parameters, therapy, and outcome. J Neurosurg 1993;78:767-775.
63. Sawaya R, Hammoud M, Schoppa D, et al: Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 1998;42:1044-1055; discussion 1055-1056.
64. Taylor MD, Bernstein M: Awake craniotomy with brain mapping as the routine surgical approach to treating patients with supratentorial intraaxial tumors: a prospective trial of 200 cases. J Neurosurg 1999;90:35-41.
65. Vorster SJ, Barnett GH: A proposed preoperative grading scheme to assess risk for surgical resection of primary and secondary intraaxial supratentorial brain tumors. Neurosurg Focus 1998;4:e2.
66. Abdulrauf SI, Edvardsen K, Ho KL, Yang XY, Rock JP, Rosenblum ML: Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J Neurosurg 1998;88:513-520.
67. Arienti VM, Botturi A, Boiardi A, et al: Adult brain low-grade astrocytomas: survival after surgery and radiotherapy. Neurol Sci 2001;22:233-238.
68. Magrini SM, Ricardi U, Santoni R, et al: Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 Italian radiation oncology centers. Int J Radiat Oncol Biol Phys 2006;65:788-799.
69. Ohgaki H, Kleihues P: Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 2005;64:479-489.
70. Pallud J, Mandonnet E, Duffau H, et al: Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas. Ann Neurol 2006;60:380-383.
71. Shinoda J, Sakai N, Nakatani K, Funakoshi T: Prognostic factors in supratentorial WHO grade II astrocytoma in adults. Br J Neurosurg 1998;12:318-324.
72. Wessels PH, Hopman AH, Kubat B, et al: Proliferation and aneusomy predict survival of young patients with astrocytoma grade II. Br J Cancer 2003;89:128-134.
73. Brandes AA, Nicolardi L, Tosoni A, et al: Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma. Neuro Oncol 2006;8:253-260.
74. Diete S, Treuheit T, Dietzmann K, Schmidt U, Wallesch CW: Sex differences in length of survival with malignant astrocytoma, but not with glioblastoma. J Neurooncol 2001;53:47-49.
75. Laws ER, Parney IF, Huang W, et al: Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 2003;99:467-473.
76. Leenstra S, Oskam NT, Bijleveld EH, Bosch DA, Troost D, Hulsebos TJ: Genetic subtypes of human malignant astrocytoma correlate with survival. Int J Cancer 1998;79:159-165.
77. Li X, Jin H, Lu Y, Oh J, Chang S, Nelson SJ: Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas. NMR Biomed 2004;17:10-20.
78. Lin CL, Lieu AS, Lee KS, et al: The conditional probabilities of survival in patients with anaplastic astrocytoma or glioblastoma multiforme. Surg Neurol 2003;60:402-406; discussion 406.
79. Beauchesne P, Pedeux R, Boniol M, Soler C: 99mTc-sestamibi brain SPECT after chemoradiotherapy is prognostic of survival in patients with high-grade glioma. J Nucl Med 2004;45:409-413.
80. Polin RS, Marko NF, Ammerman MD, et al: Functional outcomes and survival in patients with high-grade gliomas in dominant and nondominant hemispheres. J Neurosurg 2005;102:276-283.
81. Burnet NG, Jena R, Jefferies SJ, Stenning SP, Kirkby NF: Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start treatment. Clin Oncol (R Coll Radiol) 2006;18:93-103.
82. Korkolopoulou P, Patsouris E, Konstantinidou AE, et al: Mitosin and DNA topoisomerase IIalpha: two novel proliferation markers in the prognostication of diffuse astrocytoma patient survival. Appl Immunohistochem Mol Morphol 2001;9:207-214.
83. Stark AM, Hedderich J, Held-Feindt J, Mehdorn HM: Glioblastoma - the consequences of advanced patient age on treatment and survival. Neurosurg Rev 2007;30:56-61; discussion 61-62.
84. Ushio Y, Kochi M, Hamada J, Kai Y, Nakamura H: Effect of surgical removal on survival and quality of life in patients with supratentorial glioblastoma. Neurol Med Chir (Tokyo) 2005;45:454-460; discussion 460-461.
85. Wang L, Wei Q, Wang LE, et al: Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation. J Clin Oncol 2006;24:1627-1632.
86. Yuile P, Dent O, Cook R, Biggs M, Little N: Survival of glioblastoma patients related to presenting symptoms, brain site and treatment variables. J Clin Neurosci 2006;13:747-751.
87. Mernagh P, Campbell S, Dietlein M, Luster M, Mazzaferri E, Weston AR: Cost-effectiveness of using recombinant human TSH prior to radioiodine ablation for thyroid cancer, compared with treating patients in a hypothyroid state: the German perspective. Eur J Endocrinol 2006;155:405-414.
88. Shah MD, Witterick IJ, Eski SJ, Pinto R, Freeman JL: Quality of life in patients undergoing thyroid surgery. J Otolaryngol 2006;35:209-215.
89. Tagay S, Herpertz S, Langkafel M, et al: Health-related quality of life, anxiety and depression in thyroid cancer patients under short-term hypothyroidism and TSH-suppressive levothyroxine treatment. Eur J Endocrinol 2005;153:755-763.
90. Chow SM, Au KH, Choy TS, et al: Health-related quality-of-life study in patients with carcinoma of the thyroid after thyroxine withdrawal for whole body scanning. Laryngoscope 2006;116:2060-2066.
91. Kung S, Rummans TA, Colligan RC, et al: Association of optimism-pessimism with quality of life in patients with head and neck and thyroid cancers. Mayo Clin Proc 2006;81:1545-1552.
92. Tagay S, Herpertz S, Langkafel M, et al: Health-related quality of life, depression and anxiety in thyroid cancer patients. Qual Life Res 2006;15:695-703.
93. Bhat SR, Goodwin TL, Burwinkle TM, et al: Profile of daily life in children with brain tumors: an assessment of health-related quality of life. J Clin Oncol 2005;23:5493-5500.
94. Shaw EG, Rosdhal R, D'Agostino RB Jr, et al: Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol 2006;24:1415-1420.
95. Kalkanis SN, Quinones-Hinojosa A, Buzney E, Ribaudo HJ, Black PM: Quality of life following surgery for intracranial meningiomas at Brigham and Women's Hospital: a study of 164 patients using a modification of the functional assessment of cancer therapybrain questionnaire. J Neurooncol 2000;48:233-241.
96. Mohsenipour I, Deusch E, Gabl M, Hofer M, Twerdy K: Quality of life in patients after meningioma resection. Acta Neurochir (Wien) 2001;143:547-553.
97. Salo J, Niemela A, Joukamaa M, Koivukangas J: Effect of brain tumour laterality on patients' perceived quality of life. J Neurol Neurosurg Psychiatry 2002;72:373-377.
98. Eiser C, Eiser JR, Stride CB: Quality of life in children newly diagnosed with cancer and their mothers. Health Qual Life Outcomes 2005;3:29.
99. Kennedy CR, Leyland K: Comparison of screening instruments for disability and emotional/behavioral disorders with a generic measure of health-related quality of life in survivors of childhood brain tumors. Int J Cancer Suppl 1999;12:106-111.
100. Meeske K, Katz ER, Palmer SN, Burwinkle T, Varni JW: Parent proxy-reported health-related quality of life and fatigue in pediatric patients diagnosed with brain tumors and acute lymphoblastic leukemia. Cancer 2004;101:2116-2125.
101. Barr RD, Simpson T, Whitton A, Rush B, Furlong W, Feeny DH: Health-related quality of life in survivors of tumours of the central nervous system in childhood - a preference-based approach to measurement in a cross-sectional study. Eur J Cancer 1999;35:248-255.
102. Brown PD, Maurer MJ, Rummans TA, et al: A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery 2005;57:495-504.
103. Cardarelli C, Cereda C, Masiero L, et al: Evaluation of health status and health-related quality of life in a cohort of Italian children following treatment for a primary brain tumor. Pediatr Blood Cancer 2006;46:637-644.
104. Foreman NK, Faestel PM, Pearson J, et al: Health status in 52 long-term survivors of pediatric brain tumors. J Neurooncol 1999;41:47-53.
105. Glaser A, Kennedy C, Punt J, Walker D: Standardized quantitative assessment of brain tumor survivors treated within clinical trials in childhood. Int J Cancer Suppl 1999;12:77-82.
106. Odame I, Duckworth J, Talsma D, et al: Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood. Pediatr Blood Cancer 2006;46:357-362.
107. Hamilton DA: Adding concomitant and adjuvant temozolomide to radiotherapy does not reduce health-related quality of life in people with glioblastoma. Cancer Treat Rev 2006;32:483-486.
108. Taphoorn MJ, Stupp R, Coens C, et al: Health-related quality of life in patients with glioblastoma: a randomised controlled trial. Lancet Oncol 2005;6:937-944.
109. Giovagnoli AR, Silvani A, Colombo E, Boiardi A: Facets and determinants of quality of life in patients with recurrent high grade glioma. J Neurol Neurosurg Psychiatry 2005;76:562-568.
110. Maddrey AM, Bergeron JA, Lombardo ER, et al: Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma. J Neurooncol 2005;72:245-253.
111. Ribi K, Relly C, Landolt MA, Alber FD, Boltshauser E, Grotzer MA: Outcome of medulloblastoma in children: long-term complications and quality of life. Neuropediatrics 2005;36:357-365.
112. Zorc JJ, Krugman SD, Ogborn J, Benson J: Radiographic evaluation for suspected cerebrospinal fluid shunt obstruction. Pediatr Emerg Care 2002;18:337-340.
113. Cohnen M, Fischer H, Hamacher J, Lins E, Kotter R, Modder U: CT of the head by use of reduced current and kilovoltage: relationship between image quality and dose reduction. AJNR Am J Neuroradiol 2000;21:1654-1660.
114. Huda W, Lieberman KA, Chang J, Roskopf ML: Patient size and x-ray technique factors in head computed tomography examinations. II. Image quality. Med Phys 2004;31:595-601.
115. Mayo JR, Kim KI, MacDonald SL, et al: Reduced radiation dose helical chest CT: effect on reader evaluation of structures and lung findings. Radiology 2004;232:749-756.
116. Siegel MJ, Schmidt B, Bradley D, Suess C, Hildebolt C: Radiation dose and image quality in pediatric CT: effect of technical factors and phantom size and shape. Radiology 2004;233:515-522.
117. Tzedakis A, Perisinakis K, Raissaki M, Damilakis J: The effect of z overscanning on radiation burden of pediatric patients undergoing head CT with multidetector scanners: a Monte Carlo study. Med Phys 2006;33:2472-2478.
118. Donnelly LF: Reducing radiation dose associated with pediatric CT by decreasing unnecessary examinations. AJR Am J Roentgenol 2005;184:655-657.
119. Li J, Udayasankar UK, Toth TL, Seamans J, Small WC, Kalra MK: Automatic patient centering for MDCT: effect on radiation dose. AJR Am J Roentgenol 2007;188:547-552.
120. Slovis TL: Children, computed tomography radiation dose, and the As Low As Reasonably Achievable (ALARA) concept. Pediatrics 2003;112:971-972.
121. Semelka RC, Armao DM, Elias J Jr, Huda W: Imaging strategies to reduce the risk of radiation in CT studies, including selective substitution with MRI. J Magn Reson Imaging 2007;25:900-909.
122. Nishizawa K, Maruyama T, Takayama M, Okada M, Hachiya J, Furuya Y: Determinations of organ doses and effective dose equivalents from computed tomographic examination. Br J Radiol 1991;64:20-28.
123. Giles J: Study warns of 'avoidable' risks of CT scans. Nature 2004;431:391.